SILO · Silo Pharma, Inc.
$4.30
-0.16 (-3.59%)
At close · Jul 29
Going-concern doubt
— cleared May 14, 2026
The latest filing states the doubt was alleviated.
“The positive working capital serves to mitigate the conditions that historically raised substantial doubt about the Company's ability to continue as a going concern. The Company believes that it has sufficient cash and liquid short-term investments to meet its obligations for a minimum of twelve months from the date of this filing.”View the 10-Q filed May 14, 2026
Market Cap
$69.95M
Shares
16.27M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$1
as of 2026-02-20
Remaining Authorization
$1,000,000
as of 2024-04-04
· not restated in filings since 2024-05-13